Our data confirms the strong association between CD8+ T cell infiltration and the MSI status of a colon cancer, consistent with the notion that neoantigens driven by DNA MMR deficiency and subsequent frameshift mutation of target genes is operative [8], as well as CD8+ T cells are associated with improved survival from colon cancer [19]. This evidence concerns the gene CD8A and colonic neoplasm.